DUX4 and Facioscapulohumeral dystrophy: Apabetalone’s transcriptional effects went beyond direct DUX4 target genes; BET inhibition also upregulated DUX4-downregulated KEGG pathways related to metabolism and cell death [9], which have clear roles in FSHD pathology.